LMC and Manna Research announce merger of research operations

LMC and Manna Research announce merger of research operations


LMC Diabetes & Endocrinology and Manna Research are pleased to announce the merger of their research operations creating one of the largest networks of fully-owned and integrated outpatient clinical research sites in North America.

LMC has built a global reputation by offering leading sites for diabetes and obesity research and conducting top quality research that is paired with the largest group of endocrinologists worldwide. LMC currently has nine clinical practices and research sites across Quebec, Ontario and Alberta. Manna Research works in clinical research across all areas of primary care and has four sites across Canada “The merger of LMC and Manna offers pharmaceutical and biotechnology sponsors unparalleled access to high quality research sites in Canada,” said Dr. Ronnie Aronson, chief medical officer of LMC.

The two companies will still operate under their respective brands as LMC Diabetes & Endocrinology Research and Manna Research maintain their focus in their respective areas of expertise. “LMC and Manna are each leaders in the industry for their recruitment of patients and quality of data,” said Karri Venn, director of research at LMC. “We have already started streamlining best practices of both organizations and integrating the quality systems built on an extensive history of regulatory and sponsor inspections.”

LMC also offers in-patient-clinical pharmacology (Phase I) studies in its state-of-the art facility in Toronto. “The expertise that LMC has shown in performing clinical pharmacology studies in diabetic patients can now be augmented by the experience that Manna has in running primary care studies,” said Dr. Graham Wood, president of research at Manna. “The LMC facility, experience of the staff and access to primary care patients offered by Manna allows us to offer one of the best clinical pharmacology units in North America for patient-based studies.”

About LMC Diabetes & Endocrinology

Founded by Dr. Ronnie Aronson in 1997, LMC Diabetes & Endocrinology is Canada’s leading national diabetes, endocrinology and metabolic disease practice, serving Canadian patients with diabetes and other general endocrinology concerns. LMC’s national practice is led by 33 endocrinologists in nine clinics in Ontario, Alberta and Quebec. LMC’s 160+ member team of healthcare professionals provide multidisciplinary community-based care to Canadian diabetics and endocrinology patients with a focus on education, service excellence and meeting their comprehensive medical needs. The team also operates full-service pharmacies and an online platform for diabetes education, material and supplies at http://www.diabetessource.ca/. LMC stands among global leaders in early through late stage endocrinology and metabolic disease clinical research, with nine Canadian sites and a dedicated Phase I research facility in Toronto. LMC has consistently been recognized among Canada’s Best Workplaces® by the Great Place to Work Institute.

About Manna Research
Manna Research is Canada’s leading group of fully owned primary care clinical investigator sites. Headquartered in Montreal, Manna Research has been conducting clinical studies since 1996 and is now operating in Toronto, Vancouver, Quebec City and Montreal. Manna consistently delivers its clients quality data and simplifies the clinical research process by providing a trusted end-to-end solution that encompasses centralized feasibility and contracts and utilizes a set of standard operating procedures across all sites.

For more information, please contact Karri Venn (President, Research) at [email protected]


Post A Comment

Your email address will not be published. Required fields are marked *